SJ
Sudhir Jairam Vaid
About Sudhir Jairam Vaid
Sudhir Jairam Vaid has 21 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Concord Biotech Limited and Sudman Consultants Private Limited. Formerly with 2 companies, such as Celliimune Therapeutics Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Concord Biotech Limited
L24230GJ1984PLC007440
|
Managing Director | 14 Feb 2011 | 1984 | Active |
Sudman Consultants Llp
AAB-0388
|
Designated Partner | 26 Jul 2012 | 2012 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Celliimune Therapeutics Private Limited
U73200GJ2022PTC132415
|
Director | 02 Apr 2024 | 2022 | Active |
Sudman Consultants Private Limited
U74140GJ2004PTC043545
|
Director | 02 Aug 2005 | 2004 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudhir Jairam Vaid
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudhir Jairam Vaid
Sudhir Jairam Vaid has 21 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Concord Biotech Limited and Sudman Consultants Private Limited. Formerly with 2 companies, such as Celliimune Therapeutics Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Sudhir Jairam Vaid is associated with 2 companies as Managing Director and Director.
Sudhir Jairam Vaid has expertise in Technology, General Business.
Sudhir Jairam Vaid has 21 years in corporate governance.